Del Giudice Matthew Paul bought TELO
April 16, 2026 · Form 4 insider transaction
Del Giudice Matthew Paul bought 50,000 shares of Telomir Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 102 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderDel Giudice Matthew Paul
Role—
SecurityNon-Qualified Stock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 16, 2026
Filing dateJuly 27, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026.; The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.